U.K. agency favors NHS coverage of Remicade for colitis

12/17/2008 | Reuters

The U.K.'s National Institute for Health and Clinical Excellence endorsed Schering-Plough's Remicade for National Health Service coverage as an alternative for patients with ulcerative colitis who do not respond to ciclosporin.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX